Overlap of enrichment analysis with SGLT2 ligands interactions pointed out three pathways: Transmembrane transport of small molecules, SLC-mediated transmembrane transport, transport of glucose and other carbohydrates) and four disease terms (diabetes mellitus, diabetes, hyperglycemia, diabetes mellitus non-insulin-dependent), which are associated with ligands of both, SGLT2 and SGLT1. Here, SLC5A1 is linked to diabetes mellitus.